SCHEMBL10114711

SCHEMBL10114711

CC(=O)Oc1cc(Br)c(C(=O)Nc2nc(S(C)(=O)=O)cs2)cc1Br

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCK P35557 7/20 0.38
SORT1 Q99523 1/20 0.37
RAB9A P51151 6/20 0.37
NPC1 O15118 5/20 0.37
KDM4E B2RXH2 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
MITF O75030 1/20 0.37
MAPK1 P28482 1/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
ALDH1A1 P00352 1/20 0.37
GAA P10253 1/20 0.37
CASP3 P42574 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35
HPGD P15428 1/20 0.35
RECQL P46063 1/20 0.35
SLC2A1 P11166 1/20 0.34
PDE5A O76074 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10114666 0.84 MAPK1 (0.45) GCKSORT1RAB9ANPC1KDM4E
SCHEMBL10114458 0.84 SORT1 (0.41) GCKSORT1RAB9ANPC1KDM4E
SCHEMBL4757325 0.83 SORT1 (0.43) GCKSORT1RAB9ANPC1KDM4E
SCHEMBL4757250 0.83 NPC1 (0.41) GCKSORT1RAB9ANPC1KDM4E
SCHEMBL10114456 0.82 PDE5A (0.44) GCKSORT1RAB9ANPC1KDM4E
SCHEMBL703188 0.81 ALDH1A1 (0.50) GCKRAB9ANPC1KDM4ESMN1; SMN2
SCHEMBL10114672 0.80 MAPK1 (0.39) GCKRAB9ANPC1KDM4ESMN1; SMN2
SCHEMBL12974190 0.80 GCK (0.41) GCKSORT1RAB9ANPC1KDM4E
SCHEMBL10114558 0.79 RAB9A (0.39) RAB9ANPC1KDM4ESMN1; SMN2MAPK1
SCHEMBL10114719 0.79 KDM4E (0.39) GCKSORT1RAB9ANPC1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2178852-B9 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LAB LC (US) 2016-06-22 EP disclosed
EP-2178852-B1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LAB LC (US) 2015-07-22 EP disclosed
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC GCK 1360/4885SORT1 4431/4885RAB9A 1694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.